Zona incerta as a therapeutic target in Parkinson's disease

Journal of Neurology
Krystyna Ossowska

Abstract

The zona incerta has recently become an important target for deep-brain stimulation (DBS) in Parkinson's disease (PD). The present review summarizes clinical, animal and anatomical data which have indicated an important role of this structure in PD, and discusses potential mechanisms involved in therapeutic effects of DBS. Animal studies have suggested initially some role of neurons as well as GABAergic and glutamatergic receptors of the zona incerta in locomotion and generation of PD signs. Anatomical data have indicated that thanks to its multiple interconnections with the basal ganglia, thalamus, cerebral cortex, brainstem, spinal cord and cerebellum, the zona incerta is an important link in a neuronal chain transmitting impulses involved in PD pathology. Finally, clinical studies have shown that DBS of this structure alleviates parkinsonian bradykinesia, muscle rigidity and tremor. DBS of caudal zona incerta seemed to be the most effective therapeutic intervention, especially with regard to reduction of PD tremor as well as other forms of tremor.

References

Jun 15, 1992·The Journal of Comparative Neurology·T P MaJ A Rafols
Jul 22, 1992·The Journal of Comparative Neurology·U KimW C Hall
Jul 1, 1990·Trends in Neurosciences·M R DeLong
Jan 1, 1991·Movement Disorders : Official Journal of the Movement Disorder Society·T Z AzizA R Crossman
Jul 3, 1990·European Journal of Pharmacology·K OssowskaS Wolfarth
Oct 1, 1989·Trends in Neurosciences·R L AlbinJ B Penney
Dec 10, 1984·Brain Research·R D Skinner, E Garcia-Rill
Jan 1, 1994·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·K Ossowska
Jan 1, 1994·Stereotactic and Functional Neurosurgery·J GuridiJ A Obeso
Aug 1, 1994·Journal of Neurophysiology·H BergmanM R DeLong
Apr 1, 1993·Naunyn-Schmiedeberg's Archives of Pharmacology·K OssowskaS Wolfarth
Dec 16, 1996·The Journal of Comparative Neurology·T D Aumann, M K Horne
Dec 1, 1996·Current Opinion in Neurobiology·T Wichmann, M R DeLong
Jul 3, 1998·The Journal of Comparative Neurology·C I KolmacJ Mitrofanis
Feb 3, 1999·Annals of the New York Academy of Sciences·L M Jordan
Jul 10, 1999·Neuroscience Letters·B D Power, J Mitrofanis
Jul 25, 2000·The Journal of Comparative Neurology·P VeinanteM Deschênes
Sep 15, 2001·Anatomy and Embryology·J Mitrofanis, R deFonseka
Sep 29, 2001·The New England Journal of Medicine·UNKNOWN Deep-Brain Stimulation for Parkinson's Disease Study GroupA E Lang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Basal ganglia in Parkinson's disease (MDS)

The basal ganglia is comprised of the neostriatum, the external and internal pallidal segments, the subthalamic nucleus, the substantia nigra pars reticulata, and the pars compacta of the substantia nigra. The basal ganglia circuitry is responsible for the correct execution of voluntary movements and is implicated in Parkinson's disease. Here is the latest research investigating the basal ganglia in Parkinson's disease.